BrightInsight Named Most Innovative Digital Health Solutions Platform of 2022

Global excellence award

We are excited to share that BrightInsight has been named the 2022 Most Innovative Digital Health Solutions Platform by Acquisition International Magazine. We are honored to be recognized as biopharma and medtech’s partner of choice for developing regulated digital health solutions.

Whether our customers are partnering with us to develop a companion app to a leading drug to improve adherence, add connectivity to a medical device, build a healthcare provider interface or deploy a smart algorithm to personalize patient care in real-time, we help our customers build, deploy, scale and maintain digital health solutions in a compliant manner across disease states, products and geographies. Read the interview with our CEO and Co-founder, Dr. Kal Patel here.

This latest accolade comes on the heels of the successful launch of our Disease Management Solution. Our biopharma and medtech customers and prospects had been asking us to help them better differentiate their therapies and create greater engagement with patients and providers through digital. We heard them, and built this solution, which includes a Patient App, Analytics Dashboards and Healthcare Provider Interfaces. Our Disease Management Solution delivers speed to market for regulated digital health solutions such as SaMD, enabling our customers to drive more value around their top therapy brands within months.

We launched our Disease Management Solution at the BIO International Conference, where we dominated the discussion of digital health among biopharma leaders, co-hosting the first Digital Health Thought Leadership Summit with McKinsey & Co. and Google Cloud. The year started out strong, as we added Sanofi and UCB to our stellar list of customers that includes CSL Behring, Novo Nordisk, and Roche among others.

Looking ahead to the second half of 2022, we are energized and excited for what’s on the horizon. We will be launching several SaMD and other digital solutions in the coming months, beating our record of 7 SaMD last year, and will be announcing new biopharma and medtech customers, as we continue to stay focused on our mission to improve healthcare through the power of digital.

Back to Blog